PPMD joins 81 other patient organizations in a letter led by The Everylife Foundation for Rare Diseases to the Biden Administration applauding the appointment of Dr. Janet Woodcock for the position of Acting Commissioner of the Food and Drug Administration (FDA). Dr. Woodcock continues to be a champion for rare diseases and patient focused drug development.

Download the Letter >